BRUZZI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 13.220
EU - Europa 9.471
AS - Asia 7.869
SA - Sud America 989
AF - Africa 251
OC - Oceania 100
Continente sconosciuto - Info sul continente non disponibili 11
Totale 31.911
Nazione #
US - Stati Uniti d'America 12.864
IT - Italia 3.239
SG - Singapore 2.719
GB - Regno Unito 2.236
CN - Cina 1.900
HK - Hong Kong 979
DE - Germania 801
VN - Vietnam 778
SE - Svezia 769
BR - Brasile 712
FI - Finlandia 523
FR - Francia 411
RU - Federazione Russa 329
UA - Ucraina 308
TR - Turchia 248
IN - India 232
KR - Corea 223
CA - Canada 188
ID - Indonesia 147
NL - Olanda 136
BG - Bulgaria 124
JP - Giappone 103
MX - Messico 98
BD - Bangladesh 94
AR - Argentina 91
ZA - Sudafrica 87
ES - Italia 85
AU - Australia 79
PL - Polonia 79
IQ - Iraq 67
IE - Irlanda 65
LT - Lituania 63
EG - Egitto 55
PK - Pakistan 50
IR - Iran 48
DK - Danimarca 46
VE - Venezuela 39
AT - Austria 37
CH - Svizzera 37
BE - Belgio 36
CO - Colombia 36
MY - Malesia 35
CZ - Repubblica Ceca 32
BZ - Belize 31
AE - Emirati Arabi Uniti 30
EC - Ecuador 30
CL - Cile 23
SA - Arabia Saudita 22
PH - Filippine 21
TW - Taiwan 21
NZ - Nuova Zelanda 20
RO - Romania 20
KE - Kenya 19
IL - Israele 18
PE - Perù 17
PY - Paraguay 16
JO - Giordania 15
MA - Marocco 15
TH - Thailandia 15
BO - Bolivia 14
UZ - Uzbekistan 14
GR - Grecia 13
NP - Nepal 13
PT - Portogallo 13
RS - Serbia 13
TN - Tunisia 13
DZ - Algeria 12
AL - Albania 10
KW - Kuwait 10
UG - Uganda 10
ET - Etiopia 9
EU - Europa 9
AZ - Azerbaigian 7
CR - Costa Rica 7
CY - Cipro 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
HU - Ungheria 6
KZ - Kazakistan 6
AM - Armenia 5
EE - Estonia 5
LB - Libano 5
NG - Nigeria 5
OM - Oman 5
PA - Panama 5
SI - Slovenia 5
BH - Bahrain 4
CI - Costa d'Avorio 4
HN - Honduras 4
LV - Lettonia 4
MD - Moldavia 4
NI - Nicaragua 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
GA - Gabon 3
GE - Georgia 3
GH - Ghana 3
GY - Guiana 3
Totale 31.845
Città #
Singapore 1.845
Santa Clara 1.544
Southend 1.483
Ashburn 1.270
Hong Kong 943
San Jose 808
Chandler 800
Fairfield 777
Woodbridge 571
Houston 511
Hefei 471
Jacksonville 468
Dearborn 448
Nyköping 418
Helsinki 399
Beijing 382
London 347
Seattle 292
Ann Arbor 285
Wilmington 278
Milan 245
Ho Chi Minh City 244
Cambridge 237
Rome 237
New York 220
Los Angeles 219
The Dalles 213
Seoul 206
Munich 200
Council Bluffs 165
Hanoi 159
Bologna 151
Princeton 127
Lauterbourg 123
Chicago 118
Sofia 110
Frankfurt am Main 107
Jakarta 99
Izmir 98
San Diego 97
Eugene 96
Modena 96
Moscow 96
Naples 94
Bremen 92
Shanghai 92
Orem 81
São Paulo 81
Buffalo 80
Redwood City 79
Dallas 69
Tokyo 62
Montreal 59
Johannesburg 56
Columbus 53
Florence 53
Turin 53
Warsaw 51
Fremont 48
Verona 47
Boardman 46
Chennai 42
Phoenix 42
Dublin 41
Toronto 40
Las Vegas 38
Poplar 37
Salt Lake City 37
Cairo 36
Da Nang 36
Turku 34
Dong Ket 33
Palermo 33
Denver 32
Bari 31
Belize City 31
Des Moines 31
Falls Church 31
Haiphong 30
Mexico City 30
Redondo Beach 30
Manchester 29
Albuquerque 28
Brooklyn 28
Guangzhou 28
Nuremberg 28
Atlanta 27
Rio de Janeiro 27
Padova 26
Parma 26
Amsterdam 25
Boston 25
Brno 25
Portsmouth 25
Brussels 24
Norwalk 24
Reggio Emilia 24
Stockholm 24
Brescia 23
Ottawa 23
Totale 20.383
Nome #
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 1.148
Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes 640
Lactobacillus reuteri oral administration improves periodontal disease in children and adolescents with type 1 diabetes 475
COMPLICANZE MACROVASCOLARI E MORTALITÀ NEL DIABETE TIPO 1 457
Accuracy of SenseWear Pro2 armband to predict resting energy expenditure in childhood obesity. 381
The Effect of GnRH-Analogue Therapy on the Quality of Life of Patients with Central Precocious Puberty and their Families 379
Long-term effects on growth, development, and metabolism of ALL treatment in childhood 369
CONSEGUENZE METABOLICHE A BREVE E LUNGO TERMINE IN PAZIENTI CON PUBERTÀ PRECOCE CENTRALE TRATTATI CON GNRHA IN ETÀ EVOLUTIVA: STUDIO LONGITUDINALE MONOCENTRICO 367
Central Precocious Puberty and Response to GnRHa Therapy in Children with Cerebral Palsy and Moderate to Severe Motor Impairment: Data from a Longitudinal, Case-Control, Multicentre, Italian Study 363
IMPATTO DELLA TERAPIA CON ANALOGO DEL GNRH SULLA QUALITÀ DELLA VITA DEI PAZIENTI CON CPP E DELLE LORO FAMIGLIE 362
THE IMPACT OF SENSOR-AUGMENTED INSULIN PUMP (SAP) THERAPY ON QUALITY OF LIFE (QOL) IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES (T1D) AND THEIR PARENTS 359
IPERTENSIONE IN BAMBINI ED ADOLESCENTI AFFETTI DA DIABETE DI TIPO 1: ALTA PREVALENZA IDENTIFICATA TRAMITE L’UTILIZZO DEL MONITORAGGIO PRESSORIO AMBULATORIALE 357
Longitudinal evaluation of endothelial function in children and adolescents with type 1 diabetes mellitus: a long term follow up study. 355
Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: An Italian cohort study 351
L’ipercolesterolemia familiare: terapia farmacologica 329
Approaches to dyslipidemia treatment in children and adolescents 328
Effect of Weight Loss on Markers of Inflammation and Endothelial Function in Childhood Obesity 327
VALUTAZIONE AUXO-ENDOCRINOLOGICA DEI PAZIENTI AFFETTI DA SICKLE CELL DISEASE (SCD): DATI PRELIMINARI 309
A 1-year long-term study on efficacy and safety of degludec in children and adolescents with type 1 diabetes 303
QUALITÀ DI VITA E CONTROLLO METABOLICO NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 E NEI LORO GENITORI PRIMA E DOPO IL LOCKDOWN PER COVID-19. 298
EFFICACIA E SICUREZZA DI DEGLUDEC NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 296
Unusual presentation of Rosai-Dorfman disease in a 14-month-old Italian child: a case report and review of the literature 296
COVID-19 and Type 1 Diabetes: Concerns and Challenges 295
Pituitary height and neuroradiological alterations in patients with Prader-Labhart-Willi syndrome. 291
Un dolore che sveglia di notte [Pain that wakes you up at night...] 288
Efficacy and safety of insulin degludec in children and adolescents with type 1 diabetes 288
High prevalence of hypertension in children and adolescents with type 1 diabetes identified through the 24 hours ambulatory blood pressure monitoring 287
Basi genetiche ed aspetti terapeutici delle ipercolesterolemie familiari 285
Endocrine and Metabolic Complications in Children and Adolescents with Sickle Cell Disease: An Italian Cohort Study 283
Occhio alla macrorchidia! 273
Endocrine Disrupting Chemicals and Type 1 Diabetes 271
Health-Related Quality of Life and Metabolic Control in Immigrant and Italian Children and Adolescents with Type 1 Diabetes and in their Parents 271
Longitudinal study of the endothelial function in children and adolescents affected by type 1 diabetes mellitus 270
Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic 269
Hypercholesterolemia in Childhood 266
Lipide profile, antioxidant factors and endothelial function in children and adolescent with type 1 diabetes mellitus 265
A new device for measuring resting energy expenditure in severely obese children and adolescents with and without non-alcoholic fatty liver disease. 263
Can inflammatory marker levels help in detecting early complications of childhood obesity? 260
Natural history of congenital hypothyroidism in the last two decades: what is changing? Experience of a single tertiary Italian paediatric centre 260
Efficacy and Safety of Degludec in Children and Adolescents with Type 1 Diabetes 258
Prevalence and risk factors for microalbuminuria in children and adolescents with type 1 diabetes: long-term experience of a single centre 255
High g-glutamyl-transferase fractions as new markers to identify non-alcoholic fatty liver disease in childhood obesity 254
Endothelial function in adolescents with type 1 diabetes mellitus (TIDM) [Funzione endoteliale in adolescenti con diabete di tipo 1], 253
Adrenal Hypoplasia Seemingly First as a Primary Hypoaldosteronism 252
Markers of Inflammation and Endothelial Dysfunction in Young Survivors from Acute Lymphoblastic Leukemia 252
Novel insights on the treatment of hypercholesterolemia 251
Elevata incidenza di Diabete tipo 1 tra i bambini di famiglie migranti provenienti dal Nord Africa nella regione Emilia Romagna. 250
Efficacy of telemedicine in patients with type 1 diabetes over the second year by the COVID-19 pandemic spread 249
Timely diagnosis of sitosterolemia by next generation sequencing in two children with severe hypercholesterolemia 248
Isolated hypoaldosteronism as first sign of X-linked adrenal hypoplasia congenita caused by a novel mutation in NR0B1/DAX-1 gene: a case report 247
Health-related quality of life and metabolic control in young patients with type 1 diabetes and in their parents before and after the COVID-19 lockdown 246
Auxological data and glycemic control in children and adolescents with type 1 diabetes 2-years after the COVID-19 pandemic 245
Evaluation of Bone Mineral Density in a Cohort of Children with Growth Hormone Deficiency 244
Iper CPKemia, non solo miopatie 242
A comparative study on the incidence of type 1 diabetes mellitus between children of North African migrants and Italian children in Emilia-Romagna region, Italy 241
A Novel Mutation in the TITF1 Gene in a Child with Benign Hereditary Chorea 239
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 236
High levels of serum perfluorinated compounds in children and adolescents with endocrine autoimmune disease 236
Study of inflammations' markers and insulin resistance in obese children and adolescents with and without non-alcoholic fatty liver disease. 235
Obesity and craniopharyngioma. 235
Anticancer innovative therapy congress: Highlights from the 10th anniversary edition 235
Quality of life in children and adolescents with type 1 diabetes and coeliac disease. 234
Le merendine sono tutte uguali? Quale colazione per i bambini?. 234
Arresto di crescita nei primi mesi di vita: quando l’ipolipidemia e la steatorrea fanno diagnosi. 233
EFFETTI DI UN ANNO DI PANDEMIA COVID-19 SU PARAMETRI AUXOLOGICI E CONTROLLO METABOLICO NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1. 233
Uso delle gonadotropine urinarie per la valutazione del profilo minipuberale in neonati e lattanti di sesso maschile 230
Final height and body mass index in adult survivors of childhood acute lymphoblastic leukemia treated without cranial radiotherapy: a retrospective longitudinal multicenter Italian study. 228
Incidental pituitary adenoma detection in two patients affected by Williams Syndrome: only a coincidence? 228
High Levels of Perfluorooctane Sulfonate in Children at the Onset of Diabetes 227
Storia naturale dell’ipotiroidismo congenito: cosa è cambiato negli ultimi vent’anni? 227
Ten-Year Longitudinal Study of Thyroid Function in Children with Down's Syndrome 225
Mi presento, senza tosse– amyco plasma 224
Central Precocious Puberty in Cerebral Palsy 223
Malattia celiaca e patologie endocrine autoimmuni 216
Nutrizione e diabete: punti fermi e spunti di riflessione 213
Evaluation of the quality of life in children and adolescents with type 1 diabetes, coeliac disease and healthy controls. 211
Crescita e malattia celiaca 206
Circulating miR146a and 486-5p are Altered in Obese Children with and Without Non-Alcoholic Fatty LiverDisease (NAFLD) and Correlate with Abdominal Fat and BMI 205
Torcicollo A Tuttalè! (Note) Coccolini, E.a, Bruzzi, P.b, Bergonzini, P.b, Iughetti, L.ab 204
Diagnosi genetica e valutazione della funzione endoteliale in adolescenti affetti da ipercolesterolemia familiare. 202
Obesity in patients with acute lymphoblastic leukemia in childhood. 202
The Role of 24-h Ambulatory Blood Pressure Monitoring in Children and Adolescents with Type 1 Diabetes: Early Experience of a Single Centre 198
Longitudinal study of endothelial function in children with familial hypercholesterolemia. 198
Metabolic Assessment in Children with GH Deficiency Before, During, and After Human GH Replacement Therapy 196
Human Placenta-Derived Mesenchymal Stem Cells: A Novel Protocol for Pancreatic Differentiation 196
Efficacy, safety and tolerability of statin therapy in adolescents with familial hypercholesterolaemia 194
Usefulness of CGM with iPro2 in children with T1DM and correlations between Glucose Variability and metabolic control 193
Hypercholesterolemia in Childhood: How the Response to Diet could Lead to Diagnosis. Lesson from a Case-Report 191
The impact of diabetes and celiac disease in the quality of life in children and adolescents. 184
Malattia celiaca, una rivisitazione patogenetica e clinica. 184
Early-life exposure to phthalates in a population of infants from the north of Italy: characterization and time trends 183
The Risk of Metabolic Syndrome among Dyslipidemic Children and Adolescents 183
Usefulness of serological antibodies assays to better evaluate the prevalence of SARS-CoV-2 infection in youths with type 1 diabetes 183
Copy Number Variation Analysis Increases the Number of Candidate Loci Associated with Pediatric Obesity 183
The Metabolic Negative Effect of Gonadotropin-Releasing Hormone Agonist Therapy in Childhood: Is it Short-Term and Reversible? 179
Obesity in adolescence: Its prevention and psycho-social aspects [Prevenzione e aspetti psico-sociali dell'obesità in età evolutiva] 178
Effects of 1-year COVID-19 pandemic on auxological parameters and metabolic control in young patients with type 1 diabetes 178
The rehabilitation of children and adolescents with severe or medically complicated obesity: an ISPED expert opinion document 176
Growth and nutritional evaluation in children with chronic liver disease (CLD) before and after liver transplantation 175
Disordini del comportamento alimentare e diabete mellito tipo 1 in età evolutiva: un'associazione più frequente di quanto ci si potrebbe attendere 174
Totale 26.868
Categoria #
all - tutte 106.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.600


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021541 0 0 0 0 0 0 0 0 0 224 175 142
2021/20222.269 74 211 143 199 171 139 105 127 213 189 437 261
2022/20232.998 314 281 212 256 373 376 104 278 324 106 194 180
2023/20242.454 136 133 162 246 383 272 168 282 96 100 193 283
2024/20256.443 199 133 167 426 1.090 1.010 569 376 898 323 513 739
2025/20269.988 734 347 757 1.248 1.822 863 1.685 501 961 1.070 0 0
Totale 32.269